Natxtra

Kochi, India Founded: 1972 • Age: 54 yrs
Natural supplements for health and wellness are offered by Natxtra in India.

About Natxtra

Natxtra is a Healthcare company based in Kochi (India) founded in 1972. Natural supplements for health and wellness are offered by Natxtra in India. The company has 1,638 employees. Its website natxtra.com draws about 10 thousand monthly visits. Its Indian entity Synthite Industries Private Limited reported revenue of β‚Ή3,123 Cr. Natxtra offers products and services including Ashwagandha DSTR and CurQmeg-3. Its focus areas include Health and Wellness, Nutraceuticals, Dietary Supplements and Natural Health Products.

Company details

Natural supplements are provided by Natxtra to support overall health, focusing on areas like diabetes management, immunity, and stress relief through scientifically crafted products. These supplements, derived from premium ingredients such as ashwagandha and amla, are designed to enhance physical endurance, cognitive function, and heart health without causing side effects. All products are FDA approved, vegan, and aimed at promoting holistic well-being, with options for international shipping and free returns to ensure accessibility.

  • Headquarters Kochi, India
  • Employees 1,638
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social LinkedIn Facebook Instagram YouTube
  • Legal Name Synthite Industries Pvt. Ltd
  • Date of Incorporation 23 Jul, 1970
  • Jurisdiction Kolenchery, Kerala, India
Key Metrics
  • Annual Revenue
    ₹3,123 Cr

    FY 2025 · +21% YoY

  • Net Profit
    ₹194 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹434 Cr

    FY 2025 · 14% margin

  • Employee Count
    1,638

Products & Services of Natxtra

Natxtra offers a comprehensive portfolio of products and services, including Ashwagandha DSTR and CurQmeg-3.

Ashwagandha DSTR
Herbal Supplements

Ashwagandha DSTR is utilized for improving stamina and relieving stress, contributing to enhanced physical and cognitive performance.

CurQmeg-3
Cardiac Supplements

CurQmeg-3 is employed for supporting heart health and reducing inflammation, using ingredients like curcumin and omega-3.

Apps and channels of Natxtra

its YouTube channel NatXtra has 5.12K subscribers and 30 videos.

NatXtra
YouTube 5.12K subscribers 30 videos Howto & Style
Open channel

Videos from Natxtra

The most watched videos on Natxtra's YouTube channel, NatXtra (5.12K subscribers). Click a video to play it here.

NatXtra | Gymne Mag D | Sugar Controller | 100 % Vegetarian | Shipping Worldwide
1.4M views
How Mr.Sethuraman regulated his 15 years of Diabetes | Natxtra Sethuraman Review
1.3M views
NatXtra | Gymne Mag D | Sugar Controller | 100 % Vegetarian | Shipping Worldwide
550.3K views
NatXtra | Gymne Mag D | Control Diabetes | 100% vegetarian | shipping worldwide
299.3K views

More on NatXtra.

Board of directors of Synthite Industries Private Limited (Natxtra)

Synthite Industries Private Limited is the primary company behind Natxtra. The board of Synthite Industries Private Limited currently have 5 directors; the longest-serving is Aju Jacob, appointed in 2007. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Aju Jacob
DIN 00030332
Managing Director01 Oct 200719 yrsSynthite Industries Private Limited
Varghese Jacob
DIN 00030179
Whole-time director01 Oct 200719 yrsSynthite Industries Private Limited
Paolo George
DIN 05174645
Director27 Nov 20196 yrs 10 moSynthite Industries Private Limited
Jacob Ninan Modayil
DIN 08759331
Director01 Nov 20214 yrs 11 moSynthite Industries Private Limited
Ashok Mani
DIN 06846169
Director05 Apr 20224 yrs 6 moSynthite Industries Private Limited

Financials of Natxtra

Figures of Synthite Industries Private Limited, the primary company behind Natxtra, for FY 2025. Revenue was ₹3,123 Cr (+21% year on year). Net profit was ₹194 Cr (6% margin). EBITDA was ₹434 Cr (14% margin). Revenue has grown at a compounded annual rate of +11% over three years and +13% over five years.

  • ₹3,123 CrRevenue · FY 2025 · +21% YoY
  • ₹194 CrNet profit · 6% margin
  • ₹434 CrEBITDA · 14% margin
  • ₹1.05 CrPaid-up capital
  • 1,638Employees (provident fund records)
  • +11%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Synthite Industries Private Limited are on its company page.

Premium access

Detailed financial statements for Natxtra

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Natxtra

The website of Natxtra (natxtra.com) receives about 10.2K visits a month.

  • Monthly visits
    10.2K

    ▲ 57.5% vs previous month

Similar websites

Websites whose visitors overlap most with Natxtra. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
supplysix.com
100%
95K#426,397View details
kaayaessentials.com
kaayaessentials.com
56%
–

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Natxtra (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Natxtra

Premium access

Complete news archive for Natxtra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natxtra

Natxtra was founded in 1972.

Natxtra is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.

Natxtra has 1,638 employees.

The primary company behind Natxtra, Synthite Industries Private Limited, reported revenue of β‚Ή3,123 Cr for FY 2025, up 21% year on year.

Natural supplements are provided by Natxtra to support overall health, focusing on areas like diabetes management, immunity, and stress relief through scientifically crafted products. These supplements, derived from premium ingredients such as ashwagandha and amla, are designed to enhance physical endurance, cognitive function, and heart health without causing side effects. All products are FDA approved, vegan, and aimed at promoting holistic well-being, with options for international shipping and free returns to ensure accessibility.

Natxtra offers Ashwagandha DSTR and CurQmeg-3.

Natxtra operates through Synthite Industries Private Limited.

The legal entities of Natxtra currently have 6 directors, including Paolo George, Jacob Ninan Modayil, Aju Jacob and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available